Related Experiment Video
Updated: Jul 14, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Airway remodelling in children with cystic fibrosis
Tom N Hilliard1, Nicolas Regamey, Janis K Shute
1Department of Gene Therapy, National Heart and Lung Institute, Imperial College, London, UK. tom.hilliard@ubht.nhs.uk
Insights
Early cystic fibrosis (CF) lung disease shows two airway remodeling types: inflammation-related matrix breakdown impacting lung function, and TGF-beta(1)-related reticular basement membrane thickening.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Cystic Fibrosis Research
Background:
- The interplay between airway structural changes and inflammation in early cystic fibrosis (CF) lung disease remains poorly understood.
- This study investigated airway remodeling in children with CF compared to controls.
Purpose of the Study:
- To determine the characteristics of airway remodeling in children with CF.
- To compare airway structural changes in CF patients with those in primary ciliary dyskinesia (PCD) and chronic respiratory symptoms (CRS) groups.
Main Methods:
- Cross-sectional study involving 43 children with CF, 7 with PCD, 26 with CRS, and 7 healthy controls.
- Bronchoalveolar lavage (BAL) and endobronchial biopsy were performed.
- Analysis included inflammatory cells, cytokines, proteases, matrix constituents in BAL fluid, and reticular basement membrane (RBM) thickness.
Main Results:
- Elevated elastin, glycosaminoglycans, and collagen in BALF of CF patients correlated with age and inflammatory markers.
- Matrix breakdown markers negatively correlated with pulmonary function (forced expiratory volume in 1s) in CF patients.
- RBM thickness was significantly greater in CF patients and correlated with transforming growth factor-beta(1) (TGF-beta(1)).
Conclusions:
- Two distinct airway remodeling patterns were identified in pediatric CF: matrix breakdown linked to inflammation and impaired lung function, and RBM thickening associated with TGF-beta(1).
- RBM thickening appears independent of other inflammatory markers in early CF lung disease.
Background:
The relationship between airway structural changes and inflammation is unclear in early cystic fibrosis (CF) lung disease. A study was undertaken to determine changes in airway remodelling in children with CF compared with appropriate disease and healthy controls.
Methods:
Bronchoalveolar lavage and endobronchial biopsy were performed in a cross-sectional study of 43 children with CF (aged 0.3-16.8 years), 7 children with primary ciliary dyskinesia (PCD), 26 with chronic respiratory symptoms (CRS) investigated for recurrent infection and/or cough and 7 control children with no lower airway symptoms. Inflammatory cells, cytokines, proteases and matrix constituents were measured in bronchoalveolar lavage fluid (BALF). Reticular basement membrane (RBM) thickness was measured on biopsy specimens using light microscopy.
Results:
Increased concentrations of elastin, glycosaminoglycans and collagen were found in BALF from children with CF compared with the CRS group and controls, each correlating positively with age, neutrophil count and proteases (elastase activity and matrix metalloproteinase-9 (MMP-9) concentration). There were significant negative correlations between certain of these and pulmonary function (forced expiratory volume in 1 s) in the CF group (elastin: r = -0.45, p<0.05; MMP-9:TIMP-1 ratio: r = -0.47, p<0.05). Median RBM thickness was greater in the CF group than in the controls (5.9 microm vs 4.0 microm, p<0.01) and correlated positively with levels of transforming growth factor-beta(1) (TGF-beta(1); r = 0.53, p = 0.01), although not with other inflammatory markers or pulmonary function.
Conclusions:
This study provides evidence for two forms of airway remodelling in children with CF: (1) matrix breakdown, related to inflammation, proteolysis and impaired pulmonary function, and (2) RBM thickening, related to TGF-beta(1) concentration but independent of other markers of inflammation.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Breathing

